NCT07321080

Brief Summary

This study aims to investigate differences in central sensitization among patients with chronic nociceptive pain, neuropathic pain, and mixed pain conditions. Chronic pain is a complex and multidimensional phenomenon involving sensory, cognitive, emotional, and behavioral components, often sustained by mechanisms of central sensitization that contribute to pain persistence and treatment resistance. Using a multidimensional assessment approach, the study integrates self-report questionnaires, neuropsychological evaluation, psychological measures, treatment adherence assessment, and neurophysiological investigation through laser-evoked potentials (LEP). Participants will be evaluated at baseline and after 12 months to explore differences between pain types and longitudinal changes in central sensitization, cognitive functioning, emotional status, and engagement with treatment. The findings are expected to improve the understanding of neurobiological and psychosocial mechanisms underlying different chronic pain phenotypes and to support more personalized and effective pain management strategies.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
185

participants targeted

Target at P50-P75 for all trials

Timeline
20mo left

Started Dec 2025

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress20%
Dec 2025Dec 2027

Study Start

First participant enrolled

December 15, 2025

Completed
7 days until next milestone

First Submitted

Initial submission to the registry

December 22, 2025

Completed
15 days until next milestone

First Posted

Study publicly available on registry

January 6, 2026

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 15, 2027

Expected
5 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 20, 2027

Last Updated

April 20, 2026

Status Verified

April 1, 2026

Enrollment Period

2 years

First QC Date

December 22, 2025

Last Update Submit

April 15, 2026

Conditions

Keywords

CHRONIC PAINCENTRAL SENSITIZATIONNEUROPATHIC PAINNOCICEPTIVE PAINMIXED PAINLASER-EVOKED POTENTIALSNEUROPSYCHOLOGICAL ASSESSMENT

Outcome Measures

Primary Outcomes (2)

  • neuropsychological assessment

    Central Sensitization Inventory (CSI)

    24 months

  • Neuropsychological assessment

    Cognitive functions: Montreal Cognitive Assessment (MoCA)

    24 months

Study Arms (3)

Nociceptive pain

Patients suffering from nociceptive pain

Behavioral: Neuropsychological assessmentBehavioral: Laser evoked potentials

Mixed pain

Patients suffering from mixed pain

Behavioral: Neuropsychological assessmentBehavioral: Laser evoked potentials

Neuropathic pain

Patients suffering from neuropathic pain

Behavioral: Neuropsychological assessmentBehavioral: Laser evoked potentials

Interventions

Neuropsychological assessment Standardized and ad hoc test battery for comprehensive neuropsychological assessment

Mixed painNeuropathic painNociceptive pain

Laser evoked potentials

Mixed painNeuropathic painNociceptive pain

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The sample size was estimated using G\*Power 3.1 based on the primary outcome measure, the Central Sensitization Inventory (CSI). A one-way ANOVA (omnibus test) comparing three groups (nociceptive pain, neuropathic pain, and mixed pain) with equal allocation (1:1:1) was assumed. The calculation was performed using a moderate effect size (f = 0.25), a two-sided significance level of α = 0.05, and a statistical power of 0.80. Based on these parameters, a minimum sample size of 159 participants was required (53 participants per group). Considering an expected dropout rate of approximately 15% over the 12-month follow-up period, the target enrollment was increased to approximately 185 participants, corresponding to about 62 participants per group.

You may qualify if:

  • Age between 18 and 90 years
  • Presence of chronic pain
  • Diagnosis of nociceptive pain, neuropathic pain, mixed pain, or nociplastic pain
  • Patients referring to the pain outpatient clinic
  • Patients hospitalized in pain therapy units
  • Ability to understand the study procedures and provide written informed consent

You may not qualify if:

  • Presence of severe psychiatric disorders
  • Presence of severe neurological disorders
  • Presence of oncological diseases in terminal stage

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Irccs Centro Neurolesi Bonino Pulejo

Messina, Sicily, 98066, Italy

Location

MeSH Terms

Conditions

Chronic PainNociceptive PainNeuralgia

Interventions

Neuropsychological TestsLaser-Evoked Potentials

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsPeripheral Nervous System DiseasesNeuromuscular DiseasesNervous System Diseases

Intervention Hierarchy (Ancestors)

Psychological TestsBehavioral Disciplines and ActivitiesEvoked Potentials, SomatosensoryEvoked PotentialsCortical ExcitabilityElectrophysiological PhenomenaPhysiological PhenomenaNervous System Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Psychologist

Study Record Dates

First Submitted

December 22, 2025

First Posted

January 6, 2026

Study Start

December 15, 2025

Primary Completion (Estimated)

December 15, 2027

Study Completion (Estimated)

December 20, 2027

Last Updated

April 20, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Locations